The same health care system capable of delivering innovative, intensive services sometimes fails to provide for the most routine care.

The recent improvement in payrolls and the unemployment rate are welcome news, but the plight of the long-term unemployed in the United States is considerable. The policies that have been executed since mid-2008 to foster an economic recovery have failed to deliver measurable results, and those most hurt by the current downturn are often the long-term unemployed.

This is an all too familiar story, the FDA impeding useful innovations in the US entrepreneurs here are forced to test promising medical devices in costly animal studies for years before they can advance their products into clinical trials. In response, American device makers are moving their business overseas.

This August, while thousands of Americans were dutifully attending town hall meetings to let their elected representatives know they oppose big government, big bureaucracy, high tax health care, unelected congressional staff were huddling in Washington writing their own health care bill.

Multilateral organizations in conjunction with the FDA must do more to expose the problem of counterfeit drugs and help countries tighten regulatory controls.

AEI's Scott Gottlieb argues that the focus of legislation should not be on creating employment benefits specifically targeted to H1N1, but instead on ways to mitigate risks in future pandemics by providing Americans with early vaccinations.

AEI scholars provide insights on the impact of proposed health reform, as well as guidelines for fixing the U.S. health care system.

Testimony to the U.S. Senate Committee on Health, Education, Labor, and Pensionsonimproving the functioning of the health insurance market and making health coverage more affordable.